Related Experiment Videos
Modulation of nonspecific cell-mediated growth inhibition by estrogen metabolites
Abstract:
Chronic exposure of mice to estrogens such as 17-beta estradiol and diethylstilbestrol inhibits natural killer cell-mediated cytotoxicity in vivo. In this report, we investigated the direct in vitro effects of 17-beta estradiol and its major metabolites on nonspecific effector cell function measured as the ability of naive lymphocytes to inhibit the growth of the YAC-1 lymphoma, a classical natural killer-sensitive target cell. Without exception, the effects of individual estrogen metabolites on the growth inhibitory properties of these cells were accompanied, at every concentration of compound, by identical effects on the blastogenic response of lymphocytes to the T cell lectin phytohemagglutinin. These observations suggested membrane-mediated immunomodulation of lymphocyte function by estrogen metabolites. As suggested by previous studies with quinone metabolites of benzene, the catechol estrogen metabolite 2-OH estrone was significantly more potent than the parent compound at suppressing lymphocyte functions in vitro; however, dosing regimens of 2-OH estrone that suppressed blastogenic response in vivo failed to inhibit nonspecific cell-mediated growth inhibition.
Insights
Estrogen metabolites can suppress immune cell function in vitro, impacting lymphocyte responses. However, in vivo studies showed varying effects, with some metabolites failing to inhibit cell-mediated growth inhibition.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Chronic exposure to estrogens like 17-beta estradiol and diethylstilbestrol impairs natural killer cell activity in vivo.
- Estrogens are known to modulate immune responses, but their direct in vitro effects on lymphocyte function require further investigation.
Purpose of the Study:
- To investigate the in vitro effects of 17-beta estradiol and its metabolites on nonspecific effector cell function.
- To determine if estrogen metabolites directly impact lymphocyte-mediated inhibition of lymphoma cell growth and T cell blastogenesis.
Main Methods:
- Assessing the ability of naive lymphocytes to inhibit YAC-1 lymphoma cell growth.
- Measuring the blastogenic response of lymphocytes to phytohemagglutinin (a T cell lectin).
- Comparing the effects of 17-beta estradiol and its metabolites on these functions.
Main Results:
- Estrogen metabolites, including 2-OH estrone, suppressed lymphocyte growth inhibitory properties and blastogenic responses in vitro.
- The catechol estrogen metabolite 2-OH estrone was more potent than the parent compound in vitro.
- In vivo, 2-OH estrone suppressed blastogenesis but did not inhibit nonspecific cell-mediated growth inhibition.
Conclusions:
- Estrogen metabolites can directly modulate lymphocyte function in vitro, suggesting a membrane-mediated mechanism.
- The in vitro findings do not fully translate to in vivo effects, highlighting the complexity of estrogen-immune interactions.
- Further research is needed to understand the in vivo implications of estrogen metabolite immunomodulation.